期刊文献+

类胰岛素生长因子-1调控微小RNA-145对肝癌术后复发转移的影响 被引量:2

Effects of insulin like growth factor-1 on recurrence and metastasis of hepatocellular carcinoma after hepatectomy regulated through microRNA-145
原文传递
导出
摘要 目的:探讨肝切除术后类胰岛素生长因子-1(IGF-1)的表达变化,及其对微小RNA(miRNA,miR)-145的调控在肿瘤复发转移中的作用。方法:收集吉林大学中日联谊医院2016年至2017肝癌手术患者40例,检测术后血清IGF-1浓度变化;建立小鼠肝切除模型,检测术后血清IGF-1表达变化;Transwell检测IGF-1作用后HepG2细胞侵袭能力的变化以及miR-145、E盒结合锌指蛋白2(Zeb2)的表达变化;脂质体转染mimics和miR-145 inhibitor,检测HepG2细胞侵袭能力的变化。组间比较采用t检验分析两组。结果:患者术后30 d血清IGF-1浓度[(53.90±6.53)μg/L]高于术后1 d[(43.00±6.37)μg/L,t=-3.804,P<0.01],小鼠术后21 d血清IGF-1浓度[(74.00±4.73)μg/L]高于术后3 d[(57.00±6.87)μg/L,t=-8.046,P<0.01];Transwell显示处理组细胞侵袭能力[(165.67±10.01)个]明显高于对照组[(50.66±4.04)个,t=-20.880,P<0.01],miR-145表达(0.224±0.019)低于对照组(1.000±0.042,t=20.074,P<0.01);Zeb2表达(0.91±0.25)高于对照组(0.09±0.72,t=-53.959,P<0.01);转染抑制和增强miR-145表达后,miR-145 inhibitor组Zeb2蛋白表达和细胞侵袭数目[(1.33±0.38)、(259.00±14.10)个]较miR-145 mimics组[(0.26±0.19)、(68.00±4.58)个]明显增加(P<0.01)。结论:肝切除术后IGF-1表达增加,可能通过调控miR-145影响肿瘤的复发转移。 Objective To investigate the expression of insulin-like growth factor 1(IGF-1)after hepatectomy and its mechanism for the regulation of microRNA(miRNA,miR)-145 in tumor recurrence and metastasis.Methods The enzyme linked immunosorbent assay(ELISA)kit was used to detect the changes of serum IGF-1 in patients with hepatectomy after 1,3 and 30 days.The hepatectomy model of mice was established to detect the changes of serum IGF-1 after surgery of 3,7 and 21 days.Transwell invasion assay was used to detect the effect of IGF-1 on the invasion of HepG2 cells.The expression of miR-145 and Zeb2 was dectected by qPCR and Western blotting in mice treated with IGF-1.The effect of miR-145 on the invasion of HepG2 cells was examined by Transwell invasion assay.Results The serum of IGF-1 in patients at day 30 after surgery[(53.90±6.53)μg/L]was significantly higher than that at day 1[(43.00±6.37)μg/L,t=-3.804,P<0.01],and that at day 21[(74.00±4.73)μg/L]was significantly higher than that at day 3 after surgery[(57.00±6.87)μg/L,t=-8.046,P<0.01];Transwell showed cell invasion capacity in IGF-1 group(165.67±10.01)was significantly higher than in the control group(50.66±4.04,t=-20.880,P<0.01),the miR-145 expression in IGF-1 group(0.224±0.019)was significantly lower than in the control group(1.000±0.042,t=20.074,P<0.01);the Zeb2 expression in IGF-1 group(0.91±0.25)was significantly higher than in the control group(0.09±0.72,t=-53.959,P<0.01);the expression of Zeb2 protein and cell invasion in the miR-145 inhibitor group(1.33±0.38,259.00±14.10)were significantly higher than in miR-145 mimics group(0.26±0.19,68.00±4.58,P<0.01).Conclusion The increased expression of IGF-1 after hepatectomy may affect the recurrence and metastasis of tumors through the regulation of miR-145.
作者 鄂长勇 蔡研 解英俊 杨永生 E Changyong;Cai Yan;Xie Yingjun;Yang Yongsheng(Department of Hepatobiliary and Pancreatic Surgery,China-Japan Union Hospital of Jilin University,Changchun 130021,China;Department of Oral Mucosa,Hospital of Stomatology,Jilin University,Changchun 130021,China;Department of Hepatobiliary and Pancreas Surgery,the Second Hospital of Jilin University,Changchun 130041,China)
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2020年第10期1801-1803,共3页 Chinese Journal of Experimental Surgery
基金 吉林省财政厅项目(20152027) 吉林省教育厅项目(JJKH20190072KJ)。
关键词 类胰岛素生长因子-1 微小RNA-145 肝细胞癌 肝切除术后 肿瘤复发转移 Insulin-like growth factor 1 MicroRNA-145 Hepatocellular carcinoma Hepatotectomy Recurrence and metastasis
  • 相关文献

参考文献1

二级参考文献35

  • 1Thorgeirsson SS, Lee JS, Grisham JW. Molecular prognostication of liver cancer: end of the beginning. J Hepatol, 2006,44:798-805.
  • 2Samani AA, Brodt P. The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis. Surg Oncol Clin N Am,2001,10:289- 312.
  • 3Scott CD, Ballesteros M, Madrid J, et al. Soluble insulin-like growth factor-Ⅱ/mannose 6-P receptor inhibits deoxyribonucleic acid synthesis in cultured rat hepatocytes. Endocrinology, 1996, 137 : 873 -878.
  • 4Desbois-Mouthon C, Cacheux W, Blivet-Van Eggelpol M J, et al. Impact of IGF-1R./EGFR cross-talks on hepatoma cell sensitivity to -efitinib. Int J Cancer .2006.119:2557-2566.
  • 5Stoeltzing O, Liu W, Reinmuth N, et al. Regulation of hypoxia- inducible factor-lalpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor- receptor autocrine loop in human pancreatic cancer. Am J Pathol,2003,163 : 1001- 1011.
  • 6Hartog H, Wesseling J, Boezen HM, et al. The insulin-like growth factor 1 receptor in cancer: old focus, new future. Eur J Cancer, 2007,43 : 1895-1904.
  • 7Su WW, Lee KT, Yeh YT, et al. Association of circulating insulin- like growth factor 1 with hepatocellular carcinoma: one cross- sectional correlation study. J Clin Lab Anal ,2010,24 : 195-200.
  • 8Kaseb AO, Morris JS, Hassan MM, et al. Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol,2011,29 :3892-3899.
  • 9Cariani E, Lasserre C, Seurin D, et al. Differential expression of insulin-like growth factor Ⅱ mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res, 1988, 48:6844-6849.
  • 10Breuhahn K, Vreden S, Haddad R, et al. Molecular profiling of human hepatoeellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor Ⅱ overexpression. Cancer Res, 2004,64:6058 -6064.

共引文献2

同被引文献34

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部